NGM BIOPHARMACEUTICALS INC Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2020 to Q4 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Ngm Biopharmaceuticals Inc quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2020 to Q4 2023.
  • Ngm Biopharmaceuticals Inc Weighted Average Number of Shares Outstanding, Basic for the quarter ending December 31, 2023 was 82.5M shares, a 3.18% increase year-over-year.
  • Ngm Biopharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 82.5M shares, a 3.18% increase from 2022.
  • Ngm Biopharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 80M shares, a 3.72% increase from 2021.
  • Ngm Biopharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 77.1M shares, a 12.6% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 82.5M +2.55M +3.18% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-11
Q3 2023 82.7M +2.08M +2.59% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 82.5M +3.19M +4.02% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-03
Q1 2023 82M +3.99M +5.11% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-04
Q4 2022 80M +2.87M +3.72% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-11
Q3 2022 80.6M +3.21M +4.15% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 79.3M +2.17M +2.82% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 78M +1.99M +2.62% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 77.1M Oct 1, 2021 Dec 31, 2021 10-K 2024-03-11
Q3 2021 77.4M +8.59M +12.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 77.1M +8.79M +12.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 76M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q3 2020 68.8M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 68.3M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.